Suppr超能文献

利用报销策略来指导基于价值的医疗人工智能采用和利用。

Leveraging reimbursement strategies to guide value-based adoption and utilization of medical AI.

作者信息

Venkatesh Kaushik P, Raza Marium M, Diao James A, Kvedar Joseph C

机构信息

Harvard Medical School, Boston, MA, USA.

出版信息

NPJ Digit Med. 2022 Aug 10;5(1):112. doi: 10.1038/s41746-022-00662-1.

Abstract

With the increasing number of FDA-approved artificial intelligence (AI) systems, the financing of these technologies has become a primary gatekeeper to mass clinical adoption. Reimbursement models adapted for current payment schemes, including per-use rates, are feasible for early AI products. Alternative and complementary models may offer future payment options for value-based AI. A successful reimbursement strategy will align interests across stakeholders to guide value-based and cost-effective improvements to care.

摘要

随着美国食品药品监督管理局(FDA)批准的人工智能(AI)系统数量不断增加,这些技术的融资已成为大规模临床应用的主要把关因素。适用于当前支付方案(包括按使用费率)的报销模式对早期AI产品是可行的。替代性和补充性模式可能为基于价值的AI提供未来的支付选择。成功的报销策略将使各利益相关方的利益保持一致,以指导基于价值和具有成本效益的医疗改进。

相似文献

4
Artificial Intelligence for the Otolaryngologist: A State of the Art Review.人工智能在耳鼻喉科的应用:现状综述。
Otolaryngol Head Neck Surg. 2019 Apr;160(4):603-611. doi: 10.1177/0194599819827507. Epub 2019 Feb 5.
8
Adapting to the Reimbursement Landscape: The Future of Value-Based Care.适应报销环境:价值型医疗的未来。
Heart Fail Clin. 2020 Oct;16(4):479-487. doi: 10.1016/j.hfc.2020.06.008. Epub 2020 Jul 29.
9
Who Will Pay for AI?谁将为人工智能买单?
Radiol Artif Intell. 2021 Mar 3;3(3):e210030. doi: 10.1148/ryai.2021210030. eCollection 2021 May.

引用本文的文献

本文引用的文献

2
Paying for artificial intelligence in medicine.为医学人工智能付费。
NPJ Digit Med. 2022 May 20;5(1):63. doi: 10.1038/s41746-022-00609-6.
4
Who Will Pay for AI?谁将为人工智能买单?
Radiol Artif Intell. 2021 Mar 3;3(3):e210030. doi: 10.1148/ryai.2021210030. eCollection 2021 May.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验